港股異動丨山東黃金(1787.HK)漲4.39% 剝離該非核心業務 聚焦主業
格隆匯12月28日丨山東黃金(01787.HK)漲4.39%,暫錄三連漲,報13.32港元,總市值596億港元。12月22日,公司發佈公吿稱,公司向國欣頤養投資協議轉讓舜泰廣場3號樓,成交價4.15億元,增值率157%,轉讓所得將主要用於補充公司日常經營資金,改善公司現金流。招商證券隨後發佈研報稱,山東黃金剝離該非核心業務有利於公司向主業投入更多的資源。公司復工復產穩步推進,目前基本恢復正常生產,今年以來也加快黃金資源整合步伐,海外及省內外均有項目落地。公司未來盈利和估計有望持續改善,維持“強烈推薦-A”投資評級。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.